Skip to main content
GNI  Group Ltd. logo

GNI Group Ltd. — Investor Relations & Filings

Ticker · 2160 ISIN · JP3386370005 LEI · 5299005KSTCN0WVJMQ52 T Manufacturing
Filings indexed 93 across all filing types
Latest filing 2019-05-15 Interim / Quarterly Rep…
Country JP Japan
Listing T 2160

About GNI Group Ltd.

https://www.gnipharma.com/

GNI Group Ltd. is a vertically integrated, multinational biopharmaceutical company engaged in the full spectrum of drug development, from research and clinical trials to manufacturing, sales, and marketing. The company's portfolio includes pharmaceutical drugs, traditional Chinese medicines, and medical devices. Its research and development efforts are primarily focused on creating therapies for diseases such as cancer and inflammation, with a particular emphasis on conditions prevalent in Asian populations. The group utilizes genetic information and analysis technology to advance its drug discovery programs.

Recent filings

Filing Released Lang Actions
訂正四半期報告書-第18期第2四半期(2018/04/01-2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for GNI Group Ltd. for the second quarter of the 18th fiscal period (April 1, 2018, to June 30, 2018). It contains detailed financial statements, management analysis of financial results, and business operations, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2018
2019-05-15 Japanese
訂正四半期報告書-第18期第1四半期(2018/01/01-2018/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for GNI Group Ltd. covering the first quarter of 2018. It contains detailed financial statements, management analysis of financial results, and operational updates, which aligns with the definition of an Interim/Quarterly Report (IR). Although the title mentions 'Correction' (訂正), the content is a comprehensive financial report for a period shorter than a full fiscal year, not merely an announcement or certification. Q1 2018
2019-05-15 Japanese
訂正有価証券報告書-第17期(平成29年1月1日-平成29年12月31日)
Annual Report Classification · 100% confidence The document is a 'Correction of Annual Securities Report' (訂正有価証券報告書) for GNI Group Ltd. It contains detailed financial tables, including consolidated and non-consolidated financial indicators, business history, and corporate structure. This is a comprehensive annual financial filing under Japanese law (Financial Instruments and Exchange Act). Although it is a 'correction' (訂正), it functions as the official annual report (10-K equivalent in the Japanese context). FY 2017
2019-05-15 Japanese
訂正四半期報告書-第17期第3四半期(2017/07/01-2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for GNI Group Ltd. covering the third quarter of the 17th fiscal period (July 1, 2017, to September 30, 2017). It contains detailed financial statements, management analysis of financial results, and business operations. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2019-05-15 Japanese
有価証券報告書-第18期(平成30年1月1日-平成30年12月31日)
Annual Report
2019-03-29 Japanese
四半期報告書-第18期第3四半期(2018/07/01-2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for GNI Group Ltd. for the third quarter of 2018, filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management analysis, and business updates. This fits the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-13 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.